Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Indian Journal of Transplantation ; 16(2):237-238, 2022.
Article in English | EMBASE | ID: covidwho-2066874
2.
International Journal of Pharmaceutical and Clinical Research ; 14(2):314-319, 2022.
Article in English | EMBASE | ID: covidwho-1777144

ABSTRACT

Aim: The aim of the present study to determine the emerging cases of mucormycosis in post Covid-19 disease patients. Materials and Methods: This observational study was carried out in the Department of Microbiology, Patna Medical College, Patna, Bihar, India for 1 year. Basic microbiological methods such as gram stain and KOH smear were used for the detection of MC in the received clinical specimen and morphology was seen in the microscope. Results: During study period our microbiology lab received n=30 suspected clinical specimens from N= 20 post covid-19 patients for MC diagnosis over one month period. Out of n=30 specimens, n=5 was positive for MC by gram and KOH smear method, and we saw filamentous fungi by conventional microscopic method. Conclusions: The present study concluded that the cases of life-threatening MC increase day by day in central India as post complication of covid-19 disease.

3.
Research Journal of Pharmacy and Technology ; 15(1):270-278, 2022.
Article in English | Scopus | ID: covidwho-1743256

ABSTRACT

As cardiovascular diseases are still a major cause of death in most countries, it is still relevant to look into treatment of such diseases. Dyslipidemia is one of the important identified risk factors for cardiovascular diseases. As this is largely driven by lifestyle and diet, it may be difficult to control it with lifestyle modifications alone. Currently, Statins remains to be the mainstay therapy for dyslipidemia but this is also met by problems within certain patient population. The drug may be contraindicated in certain patient groups;some patients tend to not respond to Statins;while certain patients may not tolerate the adverse events. This study looked into available literature on studies done on dyslipidemia using plant-based formulations using randomized clinical trial. Based on the review conducted, there are several plant-based formations with potential to be similar in efficacy to Statins. Some of the plants used are abundant or may be easily sourced. With the increasing popularity of food supplements or nutraceuticals, exploration on the potential of plant-based products is attractive. Despite the promising results of some studies, these will need further investigations and targeting a larger population size. Formulation options may need to be explored also focused on its stability. © RJPT All right reserved.

SELECTION OF CITATIONS
SEARCH DETAIL